Furthermore, these findings from this study demonstrate a complex relationship between fluoxetine and its effect on levels of different pro-inflammatory cytokines in treating depression, whereby it has a greater ability to significantly reduce plasma and brain IL-1β levels in a rat model of CMS. Here, IL1B is linked to major depressive disorder.